What is Lucid Diagnostics's net investment in lease?

Lucid Diagnostics (LUCD) reported net investment in lease of $1.59M in Q1 2026.

How has Lucid Diagnostics's net investment in lease changed year-over-year?

Lucid Diagnostics's net investment in lease decreased by 35.2% year-over-year, from $2.45M to $1.59M.

What is the long-term trend for Lucid Diagnostics's net investment in lease?

Over 3 years (2022 to 2025), Lucid Diagnostics's net investment in lease has grown at a -3.5% compound annual growth rate (CAGR), from $2.01M to $1.81M.

Lucid Diagnostics LUCD Net Investment in Lease

Net Investment in Lease at other companies

Castle BiosciencesCSTL

——

Guardant HealthGH

——

Biodesix, Inc.BDSX

——

Personalis, Inc.PSNL

——

GeneDx HoldingsWGS

——

Quest DiagnosticsDGX

——

Other financials

Income statement

See full

Revenue$1.3M+51.7%

Gross profit-$369.0K+49.0%

Operating income-$12.1M+3.0%

Net income-$13.9M+48.3%

EPS (diluted)-$0.10+60.0%

Balance sheet

See full

Cash & equivalents$27.9M+10.6%

Total debt$1.6M-35.1%

Total equity$4.0M+174%

Total assets$34.1M+3.9%

Cash flow

See full

Operating cash flow-$12.1M+2.9%

CapEx$215.0K+131%

Free cash flow-$12.3M+1.9%

Valuation

See full

Market cap$204.13M+58.5%

Enterprise value$177.85M+78.0%

P/S39.8×+10.2×

Profitability

See full

Gross margin-66.8%—

Operating margin-959.6%-133pp

Net margin-876.7%-254pp

FCF margin-1,099.6%—

Returns & leverage

See full

Return on equity-710.6%—

Debt / equity0.4×—

Current ratio1.1×+0.3×

Where this comes from

Reported directly by Lucid Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lucid Diagnostics's net investment in lease?: Lucid Diagnostics (LUCD) reported net investment in lease of $1.59M in Q1 2026.
How has Lucid Diagnostics's net investment in lease changed year-over-year?: Lucid Diagnostics's net investment in lease decreased by 35.2% year-over-year, from $2.45M to $1.59M.
What is the long-term trend for Lucid Diagnostics's net investment in lease?: Over 3 years (2022 to 2025), Lucid Diagnostics's net investment in lease has grown at a -3.5% compound annual growth rate (CAGR), from $2.01M to $1.81M.